Dahl SG[au] - Search Results

Year	Number of Results
1969	1
1972	1
1973	1
1974	3
1975	1
1976	7
1977	3
1981	2
1982	6
1986	4
1987	3
1988	2
1989	1
1990	4
1991	8
1992	3
1993	2
1994	3
1995	1
1996	8
1997	5
1998	3
1999	1
2001	4
2002	1
2003	2
2004	1
2005	6
2006	2
2008	1
2009	3
2010	2
2011	2
2019	1
2020	1
2022	0

1

From genomics to drug targets.

Dahl SG, Sylte I. Dahl SG, et al. J Psychopharmacol. 2006 Jul;20(4 Suppl):95-9. doi: 10.1177/1359786806066088. J Psychopharmacol. 2006. PMID: 16785277 Review.

2

Structures and models of transporter proteins.

Dahl SG, Sylte I, Ravna AW. Dahl SG, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):853-60. doi: 10.1124/jpet.103.059972. Epub 2004 Feb 26. J Pharmacol Exp Ther. 2004. PMID: 14988415 Review.

3

Pharmacokinetics of antipsychotic drugs in man.

Dahl SG. Dahl SG. Acta Psychiatr Scand Suppl. 1990;358:37-40. doi: 10.1111/j.1600-0447.1990.tb05283.x. Acta Psychiatr Scand Suppl. 1990. PMID: 1978485 Review.

4

Bioinformatics and receptor mechanisms of psychotropic drugs.

Dahl SG, Edvardsen Ø, Kristiansen K, Sylte I. Dahl SG, et al. Biotechnol Annu Rev. 2001;7:165-77. doi: 10.1016/s1387-2656(01)07036-3. Biotechnol Annu Rev. 2001. PMID: 11686043 Review.

5

Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework.

Dahl SG, Aarons L, Gundert-Remy U, Karlsson MO, Schneider YJ, Steimer JL, Trocóniz IF. Dahl SG, et al. Basic Clin Pharmacol Toxicol. 2010 Jan;106(1):2-12. doi: 10.1111/j.1742-7843.2009.00456.x. Epub 2009 Jul 22. Basic Clin Pharmacol Toxicol. 2010. PMID: 19686541 Free article. Review.

6

Plasma level monitoring of antipsychotic drugs. Clinical utility.

Dahl SG. Dahl SG. Clin Pharmacokinet. 1986 Jan-Feb;11(1):36-61. doi: 10.2165/00003088-198611010-00003. Clin Pharmacokinet. 1986. PMID: 2868820 Review.

7

Molecular modelling of drug targets: the past, the present and the future.

Dahl SG, Sylte I. Dahl SG, et al. Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):151-5. doi: 10.1111/j.1742-7843.2005.pto960302.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733208 Free article. Review.

8

Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models.

Kapitulnik J, Pelkonen O, Gundert-Remy U, Dahl SG, Boobis AR. Kapitulnik J, et al. Among authors: dahl sg. Expert Opin Ther Targets. 2009 Jul;13(7):867-87. doi: 10.1517/14728220903018965. Expert Opin Ther Targets. 2009. PMID: 19530989 Review.

9

Pharmacokinetics of neuroleptic drugs and the utility of plasma level monitoring.

Dahl SG. Dahl SG. Psychopharmacol Ser. 1988;5:34-46. doi: 10.1007/978-3-642-73280-5_4. Psychopharmacol Ser. 1988. PMID: 2901082 Review.

10

Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects.

Dahl SG. Dahl SG. Ther Drug Monit. 1982;4(1):33-40. doi: 10.1097/00007691-198204000-00005. Ther Drug Monit. 1982. PMID: 6122292 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results